I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

At the helm of Delve Health, Wessam Sonbol is driving a revolution in decentralized and hybrid clinical trials. His platform supports studies in over 65 languages, enabling inclusive research across continents.

By integrating wearables, TeleVisits, and AI-driven tools, Delve Health has helped sponsors reduce patient dropout rates by up to 30% and accelerate trial timelines by 20%.

Wessam’s leadership spans more than 25 years in clinical research and healthcare technology. He’s managed complex Phase I–IV and 510(k) trials for global giants like Medtronic, Abbott Vascular, and Johnson & Johnson. His entrepreneurial journey includes founding Clinical Systems Consultants—scaling it across three continents—and developing platforms that achieved multi-million dollar exits.

Inspired by personal experience, Wessam is fiercely committed to patient-centricity. His innovations simplify trial access and elevate outcomes. He also co-developed Perta.io, a data mining platform that connects clinical trials, publications, and drug pipelines using AI and NLP—cutting research time by up to 40% for scientists and sponsors.

Whether it’s through founding companies or building ecosystems, Wessam doesn’t just follow the pulse of clinical research. He shapes it.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

In this episode, we sit down with Philip Morisky, Chief Optimus at Adherence, to explore the missing metric in healthcare: medication adherence.

Building on the legacy of the Morisky Medication Adherence Scale (MMAS), Philip shares how he's transforming behavioral diagnostics into actionable insights—bridging the gap between validated measurement and real-world impact. From the evolution of MMAS-8R to the launch of ATLAS™, we unpack how fidelity, training, and data intelligence are reshaping global standards in patient care.”

Welcome to the Pharma Prescribed podcast

I’m Adam Walker a Biometrics consultant looking to uncover the real stories behind life science leaders in clinical research.

Today, we have the honour of hosting Yuriy Lebid, the dynamic CEO of Pharmaxi, a leading contract research organization based in Ukraine.

Yuriy's journey is nothing short of inspiring. Since the onset of the conflict on February 24, 2022, he has not only persevered but has continued to lead and innovate in the face of adversity.

Pharmaxi LLC is a Contract Research Organization (CRO) with a keen focus on the regions of Ukraine and Poland. The organization offers a comprehensive range of services in the realm of clinical trials, with an emphasis on regulatory affairs, clinical monitoring, and data management. Under his supervision, we have developed "OnlineCRF," – an in-house Electronic Data Capture (EDC) system. This powerful tool enables efficient and accurate clinical data collection and trial monitoring. As the leader of Pharmaxi LLC, his personal objective is to establish a solid foundation for organic company growth while fostering a motivating work environment to attract talented and self-driven professionals.

Join us as we delve into Yuriy's remarkable story, exploring what drew him to the life sciences industry and how he has navigated the challenges to drive Pharmaxi's success.